Stakeholders are working to automate the prior authorization process, pending the release of standards from CMS.
Rachael Zimlich, RN, BSN
H1N1 is the most prevalent flu virus circulating this year, resulting in a less severe flu season overall than last year when H3N2 was predominant.
A new report links early treatment of influenza A/H3N2 with the drug to a 30% decrease in mortality.
Researchers have found that the microbiome in the respiratory tract contributes to how susceptible we each are to the flu. Work is underway to use this data to create a preventive tool
A new study reveals that llama antibodies may be effective in offering protection against numerous flu strains in a single vaccine
A new poll suggests that misconceptions about the flu vaccine are at a three-year high, despite the fact that more patients seem to be receiving the vaccine. Find out what physicians can do to clear the air.
A new report highlights how flu vaccination rates decline as the day progresses, and how primary care practices can use ‘nudges’ to modify patient care behaviors.
A new vaccine in development could provide increased flu protection for seniors.
It’s too early yet to say whether last year’s devastating flu season will motivate more patients to receive flu shots, but so far it looks like a good year for the vaccine.
NasoVax is still in the development stages but may eventually provide an option for patients who are immunocompromised.